Status:
COMPLETED
Sickle Cell Disease, Neurocognitive Disorders, Social Participation
Lead Sponsor:
Centre Hospitalier Universitaire de la Guadeloupe
Collaborating Sponsors:
Université des Antilles, LAboratoire ACTES
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
6-16 years
Brief Summary
This project will promote the development of transdisciplinary analyses. Neuropsychological disorders will be explored with the usual appropriate tests done by psychologists and neuropsychologists reg...
Detailed Description
Sickle cell anaemia, which is the most frequent genetic disease in France, requires an early and optimal care to reduce its morbidity and mortality. Children with sickle cell anaemia who are significa...
Eligibility Criteria
Inclusion
- Sickle cell anemia
- Age between 6 and 16 years inccuded, attending the centre of reference for sickle cell disease in Guadeloupe
- Informed consent
- Medical insurance
Exclusion
- Other sickle cell syndrome other than SS or Sb-thal
- Less than 6 years old or older than 16
- Attending other sickle cell departments
- No medical insurance
Key Trial Info
Start Date :
September 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 3 2019
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT04793854
Start Date
September 19 2018
End Date
June 3 2019
Last Update
March 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de la Guadeloupe
Pointe-à-Pitre, France, Guadeloupe, 97139